Man Group Given New $0.93 Price Target at JP Morgan Cazenove (EMG)

Equities research analysts at JP Morgan Cazenove increased their price target on shares of Man Group (LON: EMG) from $0.86 (57 GBX) to $0.93 (62 GBX) in a research note issued to investors on Friday. The firm currently has a “neutral” rating on the stock.

A number of other analysts have also recently weighed in on EMG. Analysts at UBS AG downgraded shares of Man Group to a “neutral” rating in a research note to investors on Friday. They now have a $1.58 price target on the stock. Separately, analysts at Bank of America cut their price target on shares of Man Group from $2.52 to $2.25 in a research note to investors on Friday. They now have a “buy” rating on the stock. Finally, analysts at BNP Paribas reiterated an “underperform” rating on shares of Man Group in a research note to investors on Friday. They now have a $1.06 price target on the stock.

Shares of Man Group traded down 4.13% during mid-day trading on Friday, hitting GBX 96.16. Man Group has a one year low of GBX 70.60 and a one year high of GBX 115.30. The stock’s 50-day moving average is currently GBX 82.79.

Man Group plc is the holding company for the Man group of companies and affiliated entities (the Group).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.



Latest News

Herbalife Employs PwC as Auditor
Herbalife Employs PwC as Auditor
Drug Resistant TB Bacteria Killed by Vitamin C
Drug Resistant TB Bacteria Killed by Vitamin C
AT&T Entering The Home Security Industry
AT&T Entering The Home Security Industry
Apple Avoids Billions via Tax Shelters
Apple Avoids Billions via Tax Shelters
Glass Point Solar Expanding into Middle East
Glass Point Solar Expanding into Middle East
Tallapoosa County Unemployment Rate Drops to 7%
Tallapoosa County Unemployment Rate Drops to 7%


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe